Skip to content

MDCXW MEDICUS PHARMA LTD

Follow

*W EXP 11/15/202 (warrant or right), issuer CIK 1997296

7 managers (7 13F filers) reported a position in MDCXW shares at 2024-12-31, 160,440 shares in all. 7 filers opened a position and 0 filers sold out during the quarter.

Managers
7
13F filers
7
New
7
Added
0
Reduced
0
Sold out
0
Shares held by filers
160,440

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2024

Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Anson Funds Management LPin group Anson Funds Management LP42,400$103K0.01%new13F-HRTimelineGroup
CLEAR STREET LLC41,270$36K<0.01%new13F-HR/ATimeline
Hudson Bay Capital Management LPin group Hudson Bay Capital Management…41,300$26.9K<0.01%new13F-HRTimelineGroup
Warberg Asset Management LLC27,470$18K<0.01%new13F-HRTimeline
Connective Capital Management, LLC6,000$2.11K<0.01%new13F-HRTimeline
UBS Group AGin group UBS Group AG2,000$702<0.01%new13F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%new13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.